About 300 reports

  • GLP-1 7%
  • 85% of the market share comes from insulin therapy
  • Insulin
  • Forecast
  • B. Braun Melsungen AG
  • Novo Nordisk Group
  • Ypsomed AG
  • Insulin Pumps Outlook
  • Clinical Indications for Insulin Pump Use
  • Insulin
  • World
  • Market Size
  • Animas Corporation
  • Insulet Corporation
  • Insulin: An overview
  • Others 15%
  • Insulin
  • World
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • ONE YEAR (INSULIN PUMP)
  • Market segmentation by product type
  • Insulin
  • Market Size
  • Insulet Corporation
  • Medtronic, Inc.
  • Roche Group
  • Insulin
  • GLOBAL INSULIN MARKET
  • Insulin
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Insulin pen
  • Pen brands and models differ from one another in many ways.
  • Insulin
  • Eli Lilly & Co.
  • Medtronic, Inc.
  • Novo Nordisk Group
  • Sanofi S.A.
  • CANADA - INSULIN PUMP & PUMP SUPPLIES BY PROVINCE & COVERAGE
  • CANADA - PUBLIC REIMBURSEMENT DETAILS OF INSULIN PUMP & PUMP SUPPLIES BY PROVINCE
  • Insulin
  • Medical Device
  • Europe
  • Insulet Corporation
  • Medtronic, Inc.
  • NEW-GENERATION INSULINS
  • NOVO NORDISK: GEOGRAPHICAL SEGMENTATION OF HUMAN INSULINS 2015
  • Insulin
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Market segmentation by type of insulin
  • Long-acting insulin
  • Insulin
  • Market Size
  • Lilly Endowment Inc.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Insulin: An overview
  • Insulin delivery technologies
  • Insulin
  • Europe
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Oramed Pharmaceuticals Inc.
  • INSULIN FORMULATIONS
  • INSULINS - OVERVIEW AND COMPARISON
  • Insulin
  • World
  • Demand
  • Market Size
  • Eli Lilly & Co.
  • Insulin Analogue
  • Animal Insulin
  • Insulin
  • China
  • Market Size
  • Hangzhou Sanofi Aventis Minsheng Pharmaceutical Co., Ltd
  • Jiangsu Wanbang Biological Pharmaceutical Co., Ltd
  • Insulin Analogue
  • Human Insulin
  • Insulin
  • China
  • Market Size
  • Eli Lilly & Co.
  • Hangzhou Sanofi Aventis Minsheng Pharmaceutical Co., Ltd
  • 4.5.3 LIXILAN (INSULIN GLARGINE PLUS LIXISENATIDE) - SANOFI
  • DIABETES AND OBESITY THERAPEUTICS MARKET, GLOBAL, ANNUAL REVENUE FORECAST FOR INSULIN
  • Insulin
  • World
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • INSULIN BIOSIMILARS APPROVALS AND LAUNCHES
  • 4.5 INSULIN BIOSIMILARS MARKET AND FORECAST
  • Insulin
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • Total Insulin Sensitizer Production and Demand (million Yuan)
  • Insulin Medicines Production and Demand (million Yuan)
  • Insulin
  • China
  • Bayer AG
  • Novo Nordisk Pharmaceutical Co., Ltd.
  • Zhejiang Expressway Co., Ltd.
  • GLOBAL PEPTIDE THERAPEUTICS MARKET SEGMENTATION BY DRUG CLASS
  • Intends to expand its presence in the peptide therapeutics area
  • Insulin
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • 09. Market Segmentation by Type
  • Insulin Market in Europe
  • Insulin
  • Europe
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • 3.3 Insulin Combination Therapies
  • 3.4 Non-Insulin Adjuvant Therapies
  • Insulin
  • Forecast
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • 2. Insulin Pumps
  • 2.1 An Overview
  • Insulin
  • Insulin Delivery
  • World
  • Animas Corporation
  • Insulet Corporation
  • 9.2 INSULIN
  • INDICATIVE LIST OF INSULIN DEVELOPMENTS BY VARIOUS COMPANIES
  • Insulin
  • Becton Property Group
  • Novo Nordisk Group
  • Owen Mumford Limited
  • Terumo Corporation
  • Insulin
  • PRODUCTION OF INSULIN
  • Insulin
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • 9.4 ELI LILLY AND COMPANY
  • 9.2 BIOCON

Insulin biosimilars, namely Insulin Aspart and Insulin Glargine are available in the Middle East and African Markets.

  • Insulin
  • Biocon Limited
  • Hospira, Inc.
  • Mylan Inc.
  • Sandoz Inc.
  • 8.4.2 BIOSIMILAR INSULINS PIPELINE
  • 6.2.7 TRESIBA (INSULIN DEGLUDEC)
  • Insulin
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Sanofi S.A.
  • Profiles of Insulin Producers and Major Insulin
  • VII. Insulin PRODUCER DIRECTORY
  • Insulin
  • China
  • Biological Pharmaceutical Co.
  • Eli Lilly & Co.
  • Hangzhou Sanofi Aventis Minsheng Pharmaceutical Co., Ltd
  • Insulin detemir
  • 2.10.3 BOLUS INSULIN FOR CSII
  • Insulin
  • World
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group

Insulin Lispro Protamine / Insulin Lispro - Introduction ##.

  • Insulin
  • Therapy
  • World
  • Demand

Insulin Regular Human / Insulin Isophane Human - Introduction ##.

  • Insulin
  • Therapy
  • World
  • Demand
  • 3.4 Insulin and Non-insulin Combination Therapy
  • 3.2 Non-insulin Monotherapy
  • Antidiabetics
  • Insulin
  • Therapy
  • Novo Nordisk Group
  • Oral insulin + Oral GLP-1 analog formulation
  • COMPLEX STORAGE CONDITIONS AND DISTRIBUTION POLICIES FOR INSULIN
  • Insulin
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • Sanofi S.A.